Question

collect information about various metals needed by our body and write function of these metals​

Answer 1

Answer:

..8)7)766677666666666666666

Answer 2

Answer:

Explanation:

Numerous essential biological processes in humans depend on the presence of metal ions, and their absence or scarcity may result in diseases. Therefore, metal ions are necessary to maintain human health. But some metal ions, especially the so-called heavy metal ions like mercury and lead, can be hazardous because of their poisonous properties. Although necessary for living, essential metal ions can also be harmful if present in excess. The main group of elements, such as sodium (Na), potassium (K), magnesium (Mg), and calcium (Ca), as well as vanadium (V), chromium (Cr), manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), zinc (Zn), and molybdenum, are among the metals that are currently known to be necessary for normal biological functions in humans (Mo), and cadmium (Cd), which are members of the periodic table's transition metal group. The most notable of these metals, which often exist as ions, are Fe, Co, Ni, Ca, Cu, Zn, and Cr. Fe and Co shortage causes anaemia, Cu deficiency causes anaemia, brain and heart illness, Zn deficiency causes growth retardation and skin changes, Ca deficiency causes bone loss, and Cr deficiency lowers glucose tolerance.

Platinized compounds:

There are other medications that are complexed with platinum in addition to cisplatin (1). Cisplatin is used to treat small cell lung cancer, epithelial ovarian cancer, gestational trophoblastic tumours, germ cell malignancies, and bladder, cervical, nasopharyngeal, esophageal, and head and neck cancers.

Complexes with titanium:

Titanocene (6, MTK4) and budotitane are two titanium compounds that have been discovered to function as anticancer medications (7, INN). Titanocene was the first non-platinum compound to go through clinical trials as a chemotherapeutic medication since it had demonstrated anticancer activity.

Complexes with ruthenium:

Despite the fact that no direct analogues have reached the clinic yet, ruthenium has developed compounds with the greatest potential. Two ruthenium anticancer drugs have started clinical trials: NAMI-A (8) and KP1019 (9).

Complexes of bismuth:

Some substances containing bismuth have been utilised for a range of gastrointestinal diseases due to its antacid and astringent effects.

#SPJ2